Aubra Eq
NDC 53002-2692
Product Information
Aubra Eq is a ANDA-approved product labeled by Rpk Pharmaceuticals, Inc.. This combination hormone medication is used to prevent pregnancy. It is supplied as a white product. This product entry covers the primary NDC 53002-2692 and 3 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
GREEN (C48329)
S;59
S;61
Code Structure Chart
Product Details
What is NDC 53002-2692?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- LEVONORGESTREL (UNII: 5W7SIA7YZW)
- LEVONORGESTREL (UNII: 5W7SIA7YZW) (Active Moiety)
- ETHINYL ESTRADIOL (UNII: 423D2T571U)
- ETHINYL ESTRADIOL (UNII: 423D2T571U) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)
- LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
- POVIDONE K30 (UNII: U725QWY32X)
- FD&C BLUE NO. 2 (UNII: L06K8R7DQK)
- FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
- ANHYDROUS LACTOSE (UNII: 3SY5LH9PMK)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 1440185 - {21 (ethinyl estradiol 0.02 MG / levonorgestrel 0.1 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Aubra 28 Day]
- RxCUI: 1440185 - Aubra 28 Day Pack
- RxCUI: 1440185 - Aubra EQ 28 Day Pack
- RxCUI: 242297 - levonorgestrel 0.1 MG / ethinyl estradiol 0.02 MG Oral Tablet
- RxCUI: 242297 - ethinyl estradiol 0.02 MG / levonorgestrel 0.1 MG Oral Tablet
* Please review the full disclaimer at the bottom of this page.